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Abstract A randomized controlled trial was performed
to examine the cost-eﬀectiveness of external hip pro-
tectors in the prevention of hip fractures. Since the hip
protectors were not eﬀective in preventing hip fractures
in our study, the main objective became to examine
whether the use of hip protectors results in lower average
costs per participant in the hip protector group as
compared with the control group. In addition, the
average costs of a hip fracture and subsequent rehabil-
itation in frail, institutionalized elderly were calculated.
Residents from apartment houses for the elderly, homes
for the elderly and nursing homes with a high risk for
hip fractures were randomized to the hip protector
group (n=276) or control group (n=285). Costs were
calculated for the hip fracture and subsequent rehabili-
tation until 1 year after the fracture. Six months after
each hip fracture, a nurse was interviewed and after 12
months, a questionnaire was sent to the general practi-
tioner or nursing home physician to determine the uti-
lization of health care resources. Diﬀerences in costs
between the groups were analyzed using non-parametric
bootstrapping. Eighteen hip fractures occurred in the
intervention group and 20 hip fractures (in 19 persons)
in the control group (log rank P-value=0.86). The
average costs per participant, including the costs of the
intervention, were 913 in the intervention group and
502 in the control group (cost diﬀerence of )411; 95%
conﬁdence interval: )723; 57). The average costs of a hip
fracture and subsequent rehabilitation were 8100 (95%
CI: 6716–10,010). The use of hip protectors was not
associated with lower costs. In addition, the average
costs of a hip fracture and subsequent rehabilitation in
the ﬁrst year after the fracture were estimated at 8100 in
institutionalized elderly.
Keywords Cost analysis Æ Elderly Æ Hip fracture Æ Hip
protector
Introduction
Hip fractures constitute a growing health care problem
due to the increasing number of frail elderly people.
Worldwide, the number of hip fractures was estimated at
1.26 million in 1990, and this number is expected to
increase to 4.5 million in 2050 [1]. Hip fractures are
associated with increased mortality and morbidity, loss
of independence and high costs for society [2,3,4,5].
A relatively new preventive option to reduce the
incidence of hip fractures is the hip protector. To
examine the eﬀectiveness and cost-eﬀectiveness of hip
protectors in the prevention of hip fractures, the
Amsterdam Hip Protector Study was started. This is
a large randomized controlled trial (n=561) in which
individual randomization was used to assign persons to
the intervention or control group. However, in this
study, the hip protectors were not eﬀective in reducing
the incidence of hip fractures [6]. These results were
conﬁrmed by a recent update of the Cochrane review
of Parker et al. [7].
In the latter, it was concluded that there is no evi-
dence of the eﬀectiveness of hip protectors from studies
in which individual randomization was used. However,
it was also concluded that data from studies using
Osteoporos Int (2004) 15: 964–969
DOI 10.1007/s00198-004-1632-3
N.M. van Schoor Æ M.C. de Bruyne Æ N. van der Roer
M.W. van Tulder Æ L.M. Bouter Æ P. Lips
Institute for Research in Extramural Medicine (EMGO Institute),
VU University Medical Center, Amsterdam,
The Netherlands
M.C. de Bruyne Æ N. van der Roer Æ M.W. van Tulder
Health Technology Assessment Unit,
VU University Medical Center, Amsterdam,
The Netherlands
E. Lommerse Æ P. Lips (&)
Department of Endocrinology,
VU University Medical Center,
PO Box 7057, 1007 MB Amsterdam,
The Netherlands
E-mail: p.lips@vumc.nl
Tel.: +31-20-4440614
Fax: +31-20-4440502
cluster randomization indicate that for those living in
institutional care with a high background incidence of
hip fracture, a program of providing hip protectors
appears to reduce the incidence of hip fractures.
Although a true eﬀect may be present in the studies
using cluster randomization, it is also possible that dif-
ferences between the clusters, i.e. wards or nursing
homes, or unknown co-interventions, play a role, which
may hamper validity and generalizability. Therefore, we
strongly believe that a design using individual random-
ization is preferable.
Currently, hip protectors are reimbursed in several
countries. To give more insight into the costs, the main
objective of this study was to examine whether the use of
hip protectors results in lower average costs per partic-
ipant in the hip protector group as compared to the
control group.
The second objective of this study was to calculate the
costs of a hip fracture and subsequent rehabilitation
in frail, institutionalized elderly. In the literature, two
studies were found in which the costs of a hip fracture
and subsequent rehabilitation were calculated in The
Netherlands [4,5]. In contrast to our study, these studies
were performed in elderly people from the general
population (71% and 58%, respectively, were living
independently before the fracture). Since the costs may
vary between independently living and institutionalized
elderly, we determined the costs of a hip fracture and
subsequent rehabilitation in institutionalized elderly.
Materials and methods
Design and subjects of the Amsterdam Hip Protector
Study
The economic evaluation was performed within the
framework of the Amsterdam Hip Protector Study,
a randomized controlled trial in which individual ran-
domization was used to assign persons to the interven-
tion group (n=276) or control group (n=285). The
subjects included were elderly persons, aged 70 years and
over, who were living in apartment houses for the
elderly, homes for the elderly, or nursing homes. All
participants had to have a high risk for hip fractures, i.e.
low bone density and/or a high fall risk. The contents of
the screening method and the inclusion and exclusion
criteria are described elsewhere [6]. The Ethical Review
Board of the VU University Medical Center approved
the study and all respondents (or their proxies in case of
cognitive impairment) gave informed consent.
Intervention
Participants in the intervention group received four hip
protectors, or ﬁve in case of urinary incontinence. Fur-
thermore, all participants of the intervention and control
group, or their nurses in case of cognitive impairment,
received a leaﬂet with information on bone health and
extrinsic risk factors for falls.
Economic analysis
The costs were calculated from a societal perspective.
However, only direct health care costs were calculated,
including the costs of hospitalization, surgery, consul-
tations with the general practitioner and physiothera-
pist, and admission to a home for the elderly or nursing
home. Direct non-health care costs, such as travel time
to the hospital and waiting time, and indirect costs due
to absenteeism from work, were considered of minor
relevance in frail, institutionalized, elderly people.
To determine the costs of a hip fracture and sub-
sequent rehabilitation, data regarding the use of health
care resources were gathered for 1 year. Six months after
each hip fracture, a nurse of the ward where the par-
ticipant was living, was interviewed. After 12 months,
a questionnaire was sent to the general practitioner
or nursing home physician. Cost prices were estimated
according to the Dutch guidelines for cost analysis in
health care research [8]. An overview of all prices is
presented in Table 1. When a person was admitted from
a home for the elderly to a nursing home, the cost
diﬀerence was used in the analyses ( 145–67 per day).
Table 1 Prices used in the economic evaluation
Euro
Intervention
Hip protector (per Safehip) 70
Information (per leaﬂet) 0.45
Ambulance drive 156
Taxi drive 22
Academic hospital (per day)
Normal care 356
Special care 573
General hospital (per day)
Normal care 253
Special care 573
General practitioner (per consultation)
By phone 9
Visit or in practice 18
Physiotherapy
Academic hospital (per 30 min) 25
General hospital (per 30 min) 26
Visit at home (per consultation) 38
Other (per consultation) 19
Occupational therapy (per consultation) 19
Home for the elderly (per day) 67
Nursing home (per day) 145
Home care (per hour) 24
Family care (per hour) 9
Walking devicesa
Walking stick 9
Walking frame 66
Rollator 153
Wheelchair 453
aThe costs of other devices, such as a toilet chair and anti-decubitus
mattress, are not shown in the table
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The costs of walking aids and other devices were esti-
mated by asking three large suppliers in The Nether-
lands for their retail prices. For each device, the lowest
price was used. In addition, the distributor of the Safe-
hip hip protector was asked for his retail price.
Costs of surgery
Costs of surgery were calculated according to the
bottom-up method, which is the method of ﬁrst choice
to estimate cost prices, because it uses individual pa-
tient data to estimate the costs of the operating-room,
the personnel present during surgery, and materials
used. Data on all hip fracture admissions (ICD codes
820.0 through 820.9) to the VU University Medical
Center in 2000 and 2001 were extracted from the
hospital information system (250 admissions, 244 per-
sons). Discharge letters were used to gather additional
information. The following inclusion criteria were
used: (1) aged 70 years or older; and (2) hemiar-
throplasty or osteosynthesis. Twenty-ﬁve admissions
were excluded due to: incomplete data (n=18), pri-
mary hip fracture before 2000 (n=3), pathological
fracture (n=2) and fracture due to traﬃc accident
(n=2). In total, 225 admissions in 221 diﬀerent pa-
tients were included. There were 91 admissions for a
hemiarthroplasty and 134 for an osteosynthesis. The
characteristics of the included patients are presented in
Table 2. The costs of the operating room and the
personnel present during surgery were estimated at
1195 per hour. The average duration of surgery was
2.45 h for the hemiarthroplasty and 2.23 h for the
osteosynthesis. The total average costs per patient,
including the costs of operation materials, were 3977
for the hemiarthroplasty and 3125 for the osteosyn-
thesis. These results were used in the economic anal-
yses.
Statistical analysis
First, the average costs of all hip fractures (n=38) that
occurred within the Amsterdam Hip Protector Study
were calculated. Second, the average costs of hip frac-
tures in both the intervention group (n=18) and control
group (n=20) were calculated. Third, the average costs
for the total intervention group (n=276), including the
costs of hip protectors and the provided information,
and the total control group (n=285) were calculated.
Sensitivity analyses were performed for the most
important cost components, i.e. hospital stay (including
surgery) and admission to a home for the elderly or
nursing home [4]. First, the inﬂuence of type of hospital,
i.e. academic or general, was examined by replacing the
costs of the academic hospital days by the costs of
general hospital days. Second, the costs for the academic
personnel present during surgery were replaced by the
costs of general hospital personnel. Third, the costs were
calculated after assuming that everyone was living in a
nursing home before the fracture in order to correct for
the diﬀerent admission rates between the intervention
and control group.
Because of skewed cost data, bias-corrected and
accelerated bootstrapping with 2000 replications was
used to calculate average costs, cost diﬀerences and
accompanying 95% conﬁdence intervals [9]. All analyses
were performed by homemade Splus subroutines for
bootstrapping (hj.ader@vumc.nl). All costs were esti-
mated for the year 2001. If the costs were not available
for that year, inﬂation ﬁgures of the Dutch Central
Bureau of Statistics (CBS) were used to calculate the
costs for 2001.
Results
In total, 561 elderly persons were included in the trial.
The demographic characteristics of the intervention
group and control group and the hip fracture patients
are presented in Table 3. There was no statistically sig-
niﬁcant diﬀerence in the incidence of hip fractures (log
rank P-value=0.86). In the intervention group, 18 per-
sons fractured a hip versus 19 persons in the control
group [6]. In the control group, one person fractured
two hips, making a total of 38 hip fractures in the study.
Compliance changed from 61% after 1 month until 37%
after 12 months [10]. Four persons in the intervention
group were wearing the hip protector while fracturing
the hip. During the follow-up of the study (average
survival time 69.6 weeks), 83 persons of the intervention
group and 79 persons of the control group died (log rank
P-value=0.31). Furthermore, within 1 year, 20 of 37 hip
fracture patients (54.1%) died.
All interviews and questionnaires regarding health
care utilization after a hip fracture were returned to the
investigator. Table 4 shows that the mean number of
academic hospital days and the mean number of con-
sultations with the general practitioner and physiother-
Table 2 Characteristics of patients admitted to the VU University
Medical Center for hip fracture surgery in 2000 and 2001
Hemiarthroplasty
(88 patients, 91
admissions)
Osteosynthesis
(133 patients,
134 admissions)
Age in yearsa 83.1±6.4 84.9±6.2
Femaleb 70 (76.9%) 107 (79.9%)
Causeb
Fall inside 73 (80.2%) 103 (76.9%)
Fall outside 11 (12.1%) 26 (19.4%)
Unknown 7 (7.7%) 5 (3.7%)
Duration of surgery (h)a 2.45±1.27 2.23±0.83
Other injuriesb 8 (8.8%) 10 (7.5%)
Complications after surgeryb 56 (61.5%) 79 (59%)
Discharge typeb
Home 24 (26.4%) 50 (37.3)
Nursing home 62 (68.1%) 76 (56.7%)
Deceased 5 (5.5%) 8 (6.0%)
aPresented are the mean±SD
bPresented are the total number (and percentage) of admissions
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apist were higher in the intervention group than in the
control group. In both groups, two persons with a hip
fracture were not operated. One of these persons was not
admitted to a hospital and the other three were admitted
for 3 days or less. When excluding these persons, the
average duration in the general hospital increases to 12.3
(SD: 13.2) days in the intervention group and 10.8 (SD:
9.5) days in the control group.
The average costs of a hip fracture and subsequent
rehabilitation were 8100 (95% CI: 6716–10,010) when
including all 38 hip fractures ( 1=$0.89 at 31 December
2001).
The average costs of hospitalization were 7151 per
hip fracture in the intervention group (n=18) and 6073
per hip fracture in the control group (n=20) (Table 5).
The average costs of hospitalization and subsequent
rehabilitation were 9166 per hip fracture in the inter-
vention group and 7141 per hip fracture in the control
group. These diﬀerences were not statistically signiﬁcant.
The average costs per participant in the intervention
group, excluding the costs of the intervention, were 598
in the intervention group (n=276) and 501 in the
control group (n=285) (Table 6). When including the
costs of the intervention, the average costs per partici-
pant in the intervention group were 913 and the aver-
age costs per participant in the control group were 502.
These diﬀerences were not statistically signiﬁcant.
The sensitivity analyses did not change the above
results, although all cost diﬀerences between the inter-
vention and control groups became somewhat smaller.
Discussion
In this study, an economic evaluation was carried out
for the use of hip protectors in the prevention of hip
fractures. The average costs per participant, including
the costs of the intervention, were 913 in the interven-
tion group and 502 in the control group (cost diﬀerence
of )411; 95% conﬁdence interval: )723; 57). The
average costs of a hip fracture and subsequent rehabil-
itation were estimated at 8100 (95% CI: 6716–10,010).
Table 3 Baseline characteristics of the intervention and control
group
Intervention
group
Control
group
Total groups n=276 n=285
Age in yearsa 85.5 (81.3–89.1) 86.3 (81.5–89.9)
Femaleb 242 (87.7%) 259 (90.9%)
Nursing homeb 144 (52.2%) 133 (46.7%)
Home for the elderlyb 112 (40.6%) 134 (47.0%)
Apartment house
for the elderlyb
20 (7.2%) 18 (6.3%)
Hip fracture patients n=18 n=19c
Age in yearsa 85.2 (81.8–88.4) 85.1 (81.6–87.1)
Femaleb 16 (88.9%) 18 (94.7%)
Nursing homeb 9 (50.0%) 10 (52.6%)
Home for the elderlyb 8 (44.4%) 9 (47.4%)
Apartment house
for the elderlyb
1 (5.6%) –
aPresented are the median (and interquartile range)
bPresented are the total number (and percentage)
cTwenty hip fractures occurred in 19 persons
Table 4 Utilization of most important health care resources
Type of utilization Intervention
group
(n=18)
Control
group
(n=20)
Hospital
Academic hospital
(number of days)a
14.0±9.4 11.0±1.7
General hospital
(number of days)a
10.8±12.6 10.3±9.5
Type of surgeryb
Hemiarthroplasty 7 9
Osteosynthesis 9 8
Type unknown – 1
No surgery 2 2
General practitioner
(number of consultations)a
7.3±5.9 4.9±5.0
Physiotherapy
(number of consultations)a
25.5±23.9 18.2±26.1
Admitted fromb
Apartment house for
the elderly to nursing home
1 –
Home for the elderly to nursing home 5 3
Home for the elderly to friend’s home – 1
aPresented are the mean±SD
bPresented is the total number
Table 5 Average costs for a hip fracture and subsequent rehabili-
tation
Costs Intervention
group
(n=18)a
Control
group
(n=20)a
Diﬀerenceb
Hospital
costs
7151
(5530–9042)
6073
(4884–7364)
)1078
()3555; 1041)
Total
costs
9166
(6778–12388)
7141
(5519–8818)
)2025
()4978; 1253)
aPresented are the average costs (95% conﬁdence interval obtained
by bootstrapping)
bPresented are the diﬀerences in average costs between the inter-
vention and control group (95% conﬁdence interval obtained by
bootstrapping)
Table 6 Average costs per participant in the intervention group and
control group
Costs Intervention
group
(n=276)a
Control
group
(n=285)a
Diﬀerenceb
Hip fracture
and rehabilitation
598
(325–984)
501
(291–786)
)97
()498; 296)
Total costs
including
intervention
913
(643–1353)
502
(284–803)
)411
()723; 57)
aPresented are the average costs (95% conﬁdence interval obtained
by bootstrapping)
bPresented are the diﬀerences in average costs between the inter-
vention and control group (95% conﬁdence interval obtained by
bootstrapping)
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In the literature, three economic evaluations were
found comparing the costs and eﬀectiveness of hip
protectors. In the ﬁrst study, the authors combined hip
fracture incidence data from their own study with data
about the eﬀectiveness of hip protectors as observed in
ﬁve randomized controlled trials [11]. A disadvantage of
combining data from diﬀerent studies is that some is-
sues, such as the inﬂuence of the hip protector on the
severity of the fracture and the associated costs, cannot
be taken into account. Also, in the second and third
studies, data regarding the eﬀectiveness of hip protectors
were obtained from other studies [12,13]. In all three
studies, the use of hip protectors was associated with
lower costs. In our study, non-signiﬁcant but substan-
tially higher costs were found in the intervention group
as compared with the control group. This diﬀerence in
costs was mainly caused by the additional costs of hip
protectors. However, also the mean number of academic
hospital days and consultations with the general prac-
titioner and physiotherapist were somewhat higher in
the intervention group. There were no large baseline
diﬀerences with respect to age, sex or living situation,
which could explain these diﬀerences in health care uti-
lization.
To our knowledge, only two other studies calculated
the costs of a hip fracture in The Netherlands. In the ﬁrst
study, which was performed in 44 hip fracture patients,
it was calculated that the average costs of hip fractures
were $11,172 in 1993 ( 13,899 in 2001 after correction
for inﬂation), and the incremental costs $9540 ( 11,870
in 2001) [4]. An advantage of this study is that they were
able to calculate the incremental costs by selecting
matched controls (n=44). In our study, this was not
possible, because it was designed to examine the eﬀec-
tiveness and cost-eﬀectiveness of hip protectors. In the
second study (n=102), the average costs were estimated
at 15,338 in 1998 ( 17,253 in 2001) and the incremental
costs, as compared to the 3 months prior to hip fracture,
at 9306 ( 10,468 in 2001) [5]. In these two studies, a
top-down procedure [4] or tariﬀs [5] were used to esti-
mate the costs of hip fracture surgery.
The costs of a hip fracture and subsequent rehabil-
itation in our study were estimated at 8100. Four
explanations for the lower costs can be given. First, the
mortality rate in our population is very high: 20 of 37
hip fracture patients died within 1 year. Of these, two
persons died within a few days, and therefore costs
were low. The second reason is the shorter hospital stay
in our study: the intervention group stayed on average
14.0 days in the academic hospital and 10.8 days in the
general hospital; the control group stayed on average
11.0 days in the academic hospital and 10.3 days in the
general hospital. In the study of Van Balen et al. [5],
the mean number of hospital days was 26. The diﬀer-
ence in hospital days might be explained by the fact
that the patients in our study, who were mainly living
in homes for the elderly and nursing homes, could be
discharged more quickly than independently living
persons because of the care given in such homes. In
addition, it sometimes happens that a hip fracture pa-
tient who is living independently cannot be discharged
to his or her own home and has to wait in the hospital
until a ‘‘nursing home bed’’ comes available. The third
reason is that four of 37 patients (10.8%) were not
operated. In the study of Van Balen et al. [5], this
percentage was 7%. Potential reasons for giving con-
servative treatment are terminal illness or severe cog-
nitive impairment. The last reason for the lower costs
in our population is that almost all participants were
already living in homes for the elderly or nursing
homes. In the study of De Laet et al. [4], nursing home
admission was one of the two most important cost
components. In our study, people who were already
living in a nursing home had no extra costs; and per-
sons who came from a home for the elderly and were
discharged to a nursing home had only the additional
costs ( 145–67 per day=cost diﬀerence between nurs-
ing home and home for the elderly). In addition, be-
cause half of the population was already living in a
nursing home, they had no costs for consultations with
the general practitioner and physiotherapist because
these costs are already included in the cost price of a
nursing home day in The Netherlands [8]. We postulate
that the costs of a hip fracture and subsequent reha-
bilitation are lower for persons who are already insti-
tutionalized than in the general population, although
this could not be tested with our data, because we only
included institutionalized elderly. However, an earlier
study which was performed in the United Kingdom
was able to test this hypothesis and found that patients
who were admitted from their own homes cost signiﬁ-
cantly more than patients who were admitted from
long-term care [14].
Although the statistical power to detect a clinically
signiﬁcant diﬀerence in the incidence of hip fractures
was good [6], this study may have lacked statistical
power to detect clinically relevant diﬀerences in costs
due to the low number of events. Another limitation of
our study is that we did not include the costs of the
screening for hip fracture risk and the costs of imple-
menting the intervention. Therefore, the costs of the
total intervention and control group were somewhat
underestimated. In addition, we did not calculate the
costs of hip fracture surgery for general hospitals. We
did replace the academic personnel present during sur-
gery by the costs of general hospital personnel in the
sensitivity analyses, but in an earlier study it was sug-
gested that also the type of materials used, i.e. gamma
nails, might diﬀer [5].
The strength of our study is that the eﬀectiveness of
the hip protector and the utilization of health care re-
sources due to hip fracture were examined in the same
study. In addition, this is one of the ﬁrst large ran-
domized controlled trials on the eﬀect of hip protectors
in which individual randomization was used. Further-
more, we calculated the costs of hip fracture surgery
for academic hospitals according to the bottom-up
method.
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In conclusion, the economic evaluation indicates that
the use of hip protectors was not associated with lower
costs for hip fractures and subsequent rehabilitation in
the intervention group. In addition, the average costs of
a hip fracture and subsequent rehabilitation in the ﬁrst
year after the fracture were estimated at 8100 in insti-
tutionalized elderly.
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